Covid 19 Research using Clinical Trials (Home Page)
Assessing antibody responses, neutralizing capacity and memory B-cell functionWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (2)
Correlated MeSH Terms (4)
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The objectives of this study are (1) to determine the ex vivo neutralizing capacity and the
longevity of SARS-CoV-2-specific Ab responses and (2) to measure the memory B-cell responses
in a cohort of health care workers (HCW) recovering from severe, mild or asymptomatic
infection. By focusing on HCW, a population that is at risk for re-infection during a second
epidemic wave, the correlation between nAb levels and protection is investigated.
NCT04469634 SARS-CoV2 COVID-19 Diagnostic Test: Assessing antibody responses, neutralizing capacity and memory B-cell function
Primary Outcomes
Measure: Antibody levels over time Time: 12 months
Measure: Antibody neutralizing capacity Time: 12 months
Measure: Memory B-cell function Time: 12 months
Measure: Antibody-dependent enhancement Time: 12 months
Secondary Outcomes
Measure: Re-infection with SARS-CoV2 Time: 12 months
No related HPO nodes (Using clinical trials)